Ovid Therapeutics je proslijedio/a tweet korisnika/ceAna Mingorance
Great news for the #CDKL5 and #raredisease community! A unique code to identify CDKL5 is important to uniformly identifying this disease across all countries and languages.https://twitter.com/CNSdrughunter/status/1221800044153753605 …
Ovid Therapeutics je dodan/na,
Ana Mingorance @CNSdrughunter
Super good news for #CDKL5 deficiency disorder, we got a new ICD-10 diagnostic code that will start in October.
If your #RareDisease does not have an ICD-10 code and you want to apply for one see how we did it:
http://www.draccon.com/dracaena-report/icd10 … pic.twitter.com/w4MOd2hxuD
06:40 - 28. sij 2020.
0 replies
1 proslijeđeni tweet
4 korisnika označavaju da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.